Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
United Airlines Holdings reports Q3 results tomorrow with the Street broadly bullish but visibly less confident, a combination that sets up an interesting test for a stock down 4.5% on the week.
Options positioning remains the clearest expression of near-term caution. The put/call ratio is running at 1.16, above its 20-day average of 1.02 and roughly 0.8 standard deviations elevated. That is a continuation of the defensive tilt flagged earlier this week, when the ratio jumped sharply from below 0.93 to above 1.18 in a single session. The PCR has since pulled back slightly from that peak but remains biased toward puts. Borrow conditions add no urgency to the short side: availability is extraordinarily loose at around 3,485% of short interest, meaning there are nearly 35 shares available to borrow for every one currently lent out. Short interest itself is 5.5% of the free float, up about 0.5% on the week, but well below the 21 million shares that shorts held in early September. The lending market is not telling a squeeze story.
The analyst picture is one of intact conviction paired with steadily shrinking targets. Every firm that moved in the past two weeks cut its price target while keeping a positive rating. Susquehanna trimmed to $150 from $165 on October 7. Wells Fargo moved to $160 from $165 a day earlier. TD Cowen cut more aggressively, from $192 to $167 on October 2. The consensus mean now stands at $153, implying roughly 42% upside from the current $107 level, which puts UAL in the unusual position of being heavily endorsed by the Street while trading well below where analysts thought it would be. The factor score on analyst recommendation divergence ranks in the 93rd percentile, meaning the gap between the consensus rating and the current price is wider than almost any stock in the universe. Bears argue that repeated target cuts signal that demand assumptions are being walked back, particularly on yield and forward bookings. Bulls point to a PE of around 9x and EV/EBITDA near 6x as evidence that the market has already priced in considerable bad news.
The insider record since July has been uniformly one-directional. The President sold $3.6 million of stock on July 28 without a 10b5-1 plan. The CFO sold $1.3 million on August 3 under a pre-arranged plan, and the Chief Commercial Officer made two additional open-market sales in August totalling around $980,000, neither under a plan. Net insider activity over the past 90 days amounts to roughly 232,000 shares sold and $27.6 million in net outflows. No insider purchases appear in the record. Discretionary sales, particularly at prices between $117 and $132, now look prescient given the stock's slide to $107. Whether that reflects insider caution about the Q3 print or broader concerns about the trajectory is what tomorrow's result will clarify.
Past Q3 prints have not rewarded holders in the near term. The last three earnings events all produced negative five-day returns, ranging from roughly 2.6% to 4.6%, with DAL down 2.3% on the week and AAL off 1.4% suggesting the whole sector is under some pressure into the reporting season. The print will test whether UAL's premium international network and relative cost discipline can justify a stock price that the Street still believes is materially too low, even after months of target reductions.
See the live data behind this article on ORTEX.
Open UAL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
